Skip to main content
Gregory Huhn, MD, Infectious Disease, Chicago, IL, Mount Sinai Hospital

GregoryDavidHuhnMD

Infectious Disease Chicago, IL

Physician

Dr. Huhn is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Huhn's full profile

Already have an account?

Education & Training

  • Rush University Medical Center
    Rush University Medical CenterFellowship, Infectious Disease, 2004 - 2005
  • Duke University Hospital
    Duke University HospitalResidency, Internal Medicine, 1996 - 1999
  • Tulane University School of Medicine
    Tulane University School of MedicineClass of 1996

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2003 - 2023
  • NC State Medical License
    NC State Medical License 1997 - 2005
  • American Board of Internal Medicine Infectious Disease

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Effect of Bamlanivimab as Monotherapy or in Combination with Etesevimab on Viral Load in Patients with Mild to Moderate COVID-19  
    Barry Heller, Gregory Huhn, Valentina Stosor, Imad Shawa, JAMA
  • SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19  
    Robert L Gottlieb, Joseph Boscia, Gregory Huhn, Valentina Stosor, Imad Shawa, The New England Journal of Medicine
  • SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19  
    Robert L Gottlieb, Joseph Boscia, Gregory Huhn, Valentina Stosor, Imad Shawa, The New England Journal of Medicine
  • Join now to see all

Authored Content

  • Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
  • Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
  • Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
  • Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
  • Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
  • Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
  • Join now to see all

Press Mentions

  • Sofosbuvir and Ribavirin for Hepatitis C in Patients with HIV Coinfection
    Sofosbuvir and Ribavirin for Hepatitis C in Patients with HIV CoinfectionSeptember 19th, 2019
  • The Race for an Effective COVID-19 Treatment: Hunches, Trials and No Clear Answer
    The Race for an Effective COVID-19 Treatment: Hunches, Trials and No Clear AnswerApril 10th, 2020
  • COVID Vaccine for 12-15: Cook County to Open Vaccination Sites to Kids This Week
    COVID Vaccine for 12-15: Cook County to Open Vaccination Sites to Kids This WeekMay 12th, 2021
  • Join now to see all

Hospital Affiliations